Chinese Pediatrics of Integrated Traditional and Western Medicine ›› 2026, Vol. 18 ›› Issue (3): 214-219.doi: 10.20274/j.cnki.issn.1674-3865.2026.03.005
Previous Articles Next Articles
Received:2025-10-16
Revised:2025-11-13
Published:2026-06-25
Online:2026-06-25
Contact:
Peng ZHOU
E-mail:846180404@qq.com
CLC Number:
Muzi LI, Peng ZHOU. Mechanism of oxidative stress in children with viral pneumonia and research advances in integrated Chinese and western medicine interventions[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 214-219.
| [1] | 占达丽,李敏,王文慧,等.2017—2020年海南省4 132例儿童肺炎病例病原菌检测结果分析[J].华南预防医学,2022,48(5):627-629. |
| [2] | 麦文慧,卓珠琳,郑青,等.海口市儿童急性下呼吸道细菌感染的病原学特征及耐药性分析[J].中国热带医学,2021,21(9):833-838. |
| [3] | Pratt MTG, Abdalla T, Richmond PC,et al. Prevalence of respiratory viruses in community-acquired pneumonia in children:a systematic review and meta-analysis[J]. Lancet Child Adolesc Health,2022,6(8):555-570. |
| [4] | Cristerna TGH, González Saldaa N, Hernández PM,et al.Leukocytes and C-reactive protein levels in children with influenza-positive and influenza-negative viral pneumonia in a third-level pediatric center in Mexico city from 2011 to 2016[J]. J Pediatr Infect Dis Soc,2021,6(9):e333. |
| [5] | 刘媛,范中娥,范方勇,等.桑夏扶正汤剂联合雾化治疗小儿病毒性肺炎的临床效果及安全性评价[J].解放军医药杂志,2020,32(6):56-59. |
| [6] | Ren GL, Wang XF, Xu J, et al. Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreak[J]. Mil Med Res, 2021,8(1):13. |
| [7] | Brenes-Chacon H, Garcia-Mauriño C, Moore-Clingenpeel M, et al. Age-dependent interactions among clinical characteristics, viral loads and disease severity in young children with respiratory syncytial virus infection[J]. Pediatr Infect Dis J, 2021,40(2):116-122. |
| [8] | Guo Y X, Liu Y R, Zhao S H,et al. Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages[J]. Nat Commun,2021,12(1):7094. |
| [9] | Sharma A, Tewari D, Nabavi SF, et al. Reactive oxygen species modulators in pulmonary medicine[J]. Curr Opin Pharmacol, 2021,57:157-164. |
| [10] | 王保华,李赛美,左俊岭.白虎清解汤对小鼠流感病毒性肺炎氧化应激的动态干预作用[C]//中华中医药学会仲景学说分会.仲景医学求真(续三).广州中医药大学第一附属医院,2009:399-401. |
| [11] | Xu W, Zhao T, Xiao H. The implication of oxidative stress and AMPK-Nrf2 antioxidative signaling in pneumonia pathogenesis[J]. Front Endocrinol(Lausanne), 2020,11:400. |
| [12] | Noonong K, Chatatikun M, Surinkaew S, et al. Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis[J]. Front Immunol, 2023,14:1275001. |
| [13] | Hosakote YM, Liu T, Castro SM, et al. Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes[J]. Am J Respir Cell Mol Biol, 2009,41(3):348-357. |
| [14] | Wang F, Xie R. Knockdown of THBS1 inhibits inflammatory damage and oxidative stress in in vitro pneumonia model by regulating NF-κB signaling pathway[J]. Allergol Immunopathol(Madr), 2025,53(3):17-22. |
| [15] | To T, Terebessy E, Zhu J, et al. Does early life exposure to exogenous sources of reactive oxygen species(ROS) increase the risk of respiratory and allergic diseases in children? A longitudinal cohort study[J]. Environ Health, 2022,21(1):90. |
| [16] | Malaviya R, Meshanni JA, Sunil VR, et al. Role of macrophage bioenergetics in N-acetylcysteine-mediated mitigation of lung injury and oxidative stress induced by nitrogen mustard[J]. Toxicol Appl Pharmacol, 2024,485:116908. |
| [17] | Ahmad S, Nasser W, Ahmad A. Epigenetic mechanisms of alveolar macrophage activation in chemical-induced acute lung injury[J]. Front Immunol, 2024,15:1488913. |
| [18] | Steingruber L, Handtke S, Schweiger F, et al. Histopathological analysis of respiratory muscles in patients with acute COVID-19 infection[J]. Cell Tissue Res, 2025,401(1):59-68. |
| [19] | Barber TM, Kabisch S, Pfeiffer AFH, et al. Optimised skeletal muscle mass as a key strategy for obesity management[J]. Metabolites, 2025,15(2):85. |
| [20] | 高萍萍,宋湘.氧化应激对心血管疾病影响的研究进展[J].心血管康复医学杂志,2023,32(2):163-166. |
| [21] | Gouda NA, Zhakupova A, Abdelaal AM, et al. The interplay involving oxidative stress and autophagy: Mechanisms, implications, and therapeutic opportunities[J]. Exp Mol Pathol, 2025,143:104989. |
| [22] | Tepebaşı MY, İlhan İ, Temel EN, et al. Investigation of inflammation, oxidative stress, and DNA damage in COVID-19 patients[J]. Cell Stress Chaperones, 2023,28(2):191-199. |
| [23] | Chang JW, Chen HC, Hu HZ, et al. Phthalate exposure and oxidative/nitrosative stress in childhood asthma: a nested case-control study with propensity score matching[J]. Biomedicines, 2022,10(6):1438. |
| [24] | Chaudhary P, Janmeda P, Docea AO, et al. Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases[J]. Front Chem, 2023,11:1158198. |
| [25] | Carrasco-García Á, Herrera G, de Graaff LCG, et al. Role of mitochondrial function in the oxidative stress profile of children with Prader-Willi syndrome[J]. Free Radic Biol Med, 2025,237:397-402. |
| [26] | Li M, Li M, Hou Y, et al. Ferroptosis triggers airway inflammation in asthma[J]. Ther Adv Respir Dis, 2023,17:17534666231208628. |
| [27] | Andrade AS, Bentes AA, Diniz LM, et al. Association between single-nucleotide polymorphisms in Toll-like receptor 3 (tlr3), tlr7, tlr8 and tirap genes with severe symptoms in children presenting COVID-19[J]. Viruses, 2024,17(1):35. |
| [28] | Kim CU, Lim D, Kim YS, et al. Influenza viral matrix 1 protein aggravates viral pathogenicity by inducing TLR4-mediated reactive oxygen species production and apoptotic cell death[J]. Cell Death Dis, 2023,14(3):228. |
| [29] | Gong C, Ma J, Deng Y, et al. S100A9-/- alleviates LPS-induced acute lung injury by regulating M1 macrophage polarization and inhibiting pyroptosis via the TLR4/MyD88/NFκB signaling axis[J]. Biomed Pharmacother, 2024,172:116233. |
| [30] | He M, Ren Z, Goraya MU, et al. Anti-influenza drug screening and inhibition of apigetrin on influenza A virus replication via TLR4 and autophagy pathways[J]. Int Immunopharmacol, 2023,124(Pt B):110943. |
| [31] | Watanabe N, Fujita Y, Nakayama J, et al. Anomalous epithelial variations and ectopic inflammatory response in chronic obstructive pulmonary disease[J]. Am J Respir Cell Mol Biol, 2022,67(6):708-719. |
| [32] | Tie Y, Liu H, Zhang T, et al. Natural products alleviate viral pneumonia by modulating inflammatory and oxidative-stress pathways[J]. Front Pharmacol, 2025,16:1657829. |
| [33] | Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1[J]. EMBO J, 1991,10(8):2247-2258. |
| [34] | 倪雯婷,马大龙,邵骏菁,等.基于网络药理学和实验验证探索荆防合剂治疗甲型H1N1流感的作用机制[J].中国实验方剂学杂志,2022,28(12):200-209. |
| [35] | Niri P, Saha A, Polopalli S, et al. β-Caryophyllene attenuates oxidative stress and inflammatory response in LPS induced acute lung injury by targeting ACE2/MasR and Nrf2/HO-1/NF-κB axis[J]. Biochem Biophys Res Commun, 2025,746:151286. |
| [36] | Sivandzade F, Prasad S, Bhalerao A, et al. NRF2 and NF-κB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches[J]. Redox Biol, 2019,21:101059. |
| [37] | Toscanelli W, Fracella M, De Angelis M, et al. NRF2 antioxidant response and interferon-stimulated genes are differentially expressed in SARS-CoV-2-positive young subjects[J]. Immun Inflamm Dis, 2025,13(1):e70109. |
| [38] | Jin X, Chen L, Yang Y, et al. Adverse effects of Nrf2 in different organs and the related diseases[J]. Antioxid Redox Signal, 2025,42(16-18):973-985. |
| [39] | Shaw P, Chattopadhyay A. Nrf2-ARE signaling in cellular protection: Mechanism of action and the regulatory mechanisms[J]. J Cell Physiol, 2020,235(4):3119-3130. |
| [40] | Cho HY, Imani F, Miller-DeGraff L, et al. Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease[J]. Am J Respir Crit Care Med, 2009,179(2):138-150. |
| [41] | Georgiou-Siafis SK, Tsiftsoglou AS. The key role of GSH in keeping the redox balance in mammalian cells: mechanisms and significance of GSH in detoxification via formation of conjugates[J]. Antioxidants(Basel), 2023,12(11):1953. |
| [42] | Checconi P, De Angelis M, Marcocci ME, et al. Redox-Modulating agents in the treatment of viral infections[J]. Int J Mol Sci, 2020,21(11):4084. |
| [43] | Anwar S, Sarwar T, Khan AA, et al. Therapeutic applications and mechanisms of superoxide dismutase(SOD) in different pathogenesis[J]. Biomolecules, 2025,15(8):1130. |
| [44] | Moradi-Marjaneh R, Hassanian SM, Fiuji H, et al. Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer[J]. J Cell Physiol, 2018,233(8):5613-5622. |
| [45] | Lin X, Wang R, Zou W, et al. The influenza virus H5N1 infection can induce ROS production for viral replication and host cell death in A549 cells modulated by human Cu/Zn superoxide dismutase(SOD1) overexpression[J]. Viruses, 2016,8(1):13. |
| [46] | 郑敏敏,柳洁,赵清.药用植物黄芩的生物学研究进展及展望[J].生物技术通报,2023,39(2):10-23. |
| [47] | 周思瑶,游雷鸣,张海丽,等.汉黄芩素对LPS-ATP诱导的巨噬细胞氧化应激的抑制作用[J].中国免疫学杂志,2020,36(3):257-260. |
| [48] | Li W, Wang X, Chen Y, et al. Luteolin-7-O-glucoside promotes macrophage release of IFN-β by maintaining mitochondrial function and corrects the disorder of glucose metabolism during RSV infection[J]. Eur J Pharmacol, 2024,963:176271. |
| [49] | Liu H, You L, Wu J, et al. Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS[J]. J Leukoc Biol, 2020,108(1):253-266. |
| [50] | 张来,张秀英,魏晨浩,等.定喘颗粒对呼吸道合胞病毒肺炎模型大鼠肺组织氧化应激及Nrf2/Keap1/HO-1/NQO1信号通路的影响[J].中医杂志,2025,66(15):1588-1596. |
| [1] | Ting CAO, Lei XIONG, Zihao FENG, Dongmei MA. Professor Xiong Lei's clinical experience in treating influenza in children using the method of aromatic herbs for penetrating heat and resolving dampness [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 185-188. |
| [2] | Na ZHANG, Dan SUN, Zhengguang HUANG, Shuo YANG. Meta-analysis of the effectiveness of traditional Chinese medicine external therapy for cough variant asthma in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 189-199. |
| [3] | Xiao TIAN, Huimin CHU. Research progress in integrated traditional Chinese and western medicine treatment of refractory Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 200-206. |
| [4] | Yue ZHANG, Yanfei YANG, Yanfen WANG, Wenjing GUO. Study on the immunological mechanisms and advances in integrated Chinese-western medicine treatment of severe Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 207-213. |
| [5] | Fang YUAN, Xiaoxue MIN, Chunli FENG. "Shaoyang as the pivot" and "Sanjiao Qi transformation": on the core pathogenesis and treatment pivot of chronic cough in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 220-224. |
| [6] | Min GAO, Linlin DU. Application progress of external therapies of traditional Chinese medicine in short stature children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 225-229. |
| [7] | Ziyang JIN, Yongchang YANG. Research progress in laboratory markers and predictive models for IgA vasculitis nephritis [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 230-235. |
| [8] | Yue YUAN, Zhouying SHI, Zihui DING, Ping LI. Theoretical analysis of traditional Chinese medicine in the prevention and treatment of infectious diseases in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 236-239. |
| [9] | Meixi TONG, Xiaozheng DUAN, Aoning LIU. Syndrome-differentiated treatment for pediatric anorexia based on the constitutional characteristics of "three excesses and four deficiencies" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 260-264. |
| [10] | Xin JIA, Jie ZHANG, Feifei CHEN, Anqi WU, Liying WANG. Study on clinical efficacy of long-term vitamin D supplementation combined with comprehensive behavioral therapy in the treatment of transient tic disorder in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 272-276. |
| [11] | Lizheng JIN, Jiapei LIN, Hanyu SUN, Guangju HUANG. Research progress on influencing factors for childhood asthma control [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(2): 104-110. |
| [12] | Qing YANG, Jingnan XUE, Liujin JIA. Experience of Professor Jia Liujin in treating pediatric pneumonia with dyspnea and cough [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(2): 111-115. |
| [13] | Zhe ZHOU, Huina LU, Ming ZHANG, Ling DONG. Research on the clinical experience of Professor Xu Rongqian in treating children with cough variant asthma [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(2): 116-121. |
| [14] | Xuting WANG, Peng ZHOU. Research status of specific immunotherapy for childhood asthma [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(2): 122-127. |
| [15] | Minli GUAN, Xiaolin GAO. Advances in diagnosis and treatment of pediatric mesenteric lymphadenitis based on integrated traditional Chinese and western medicine [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(2): 128-132. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
